Key Takeaways
- The Trump Administration will continue the second cycle of the Medicare price negotiation program, but wants to increase transparency and make other potential "improvements" to the process.
The Trump Administration will continue the second cycle of Medicare price negotiations, which includes 15 drugs selected by the Biden...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?